[Asia Economy] AMCG "Launches Clinical Trial to Evaluate MCG Scan Accuracy"

☞ Go to article

AMCG announced on the 19th that it will begin clinical trials to evaluate the diagnostic accuracy of Magnetocardiography (MCG) Scan for patients suspected of coronary artery disease.

AMCG will begin multi-center clinical trials from the 19th and plans to complete clinical trials for early diagnosis of coronary artery disease by the end of 2024. The MCG Scan equipment used in this clinical trial received item approval from the Ministry of Food and Drug Safety for market sale in June last year. In March, it passed the Clinical Ethics Committee (IRB) review at Gachon University Gil Hospital and The Catholic University of Korea Eunpyeong St. Mary's Hospital.

The clinical trial is being conducted to evaluate the diagnostic accuracy of MCG Scan for early diagnosis of coronary artery disease. It will verify the effectiveness and stability of MCG Scan tests through 1:1 comparison with angiography test results for about 600 patients.

The MCG Scan owned by AMCG is a system that can diagnose heart disease without the injection of drugs such as contrast media or radiation by using SQUID (Superconducting Quantum Interference Device) sensors to detect tiny magnetic fields generated by the human body. According to the company, the MCG Scan test can complement and replace tests such as electrocardiograms currently used for the diagnosis of ischemic heart disease.

Seo Yong-sung, President of AMCG, said, "Through this clinical trial, we will accumulate sufficient clinical data for the diagnosis of heart disease. Based on this, we will secure the diagnostic excellence of MCG Scan and do our best to establish it as a global heart disease diagnostic device."

Professor Lee Kyung-hoon of the Department of Cardiology at Gachon University Gil Hospital, who is participating in this clinical trial, said, "I expect that MCG Scan tests will provide highly accurate diagnostic readings in a short time without side effects for patients. We will lead successful clinical trials to verify the diagnostic accuracy of MCG Scan tests."

[Asia Economy Reporter Lee Myung-hwan]